Search Within

Brian Carl Shaffer

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (13)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (32)
  2. Center for Hematologic Malignancies (32)
  3. Department of Medicine (32)
  4. GSK Faculty (32)
  5. Hematologic Malignancies, Division of (32)
  6. Human Oncology and Pathogenesis Program (32)

More Groups

People
  1. Sergio Giralt (23)
  2. Esperanza Papadopoulos (19)
  3. Miguel-Angel Perales (19)
  4. Boglarka Gyurkocza (18)
  5. Ann Jakubowski (16)
  6. Roni Tamari (16)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (1)

More Years

Publications
  1. Blood (9)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Blood Advances (6)
  4. American Journal of Hematology (2)
  5. Advances in Cell and Gene Therapy (1)
  6. Best Practice and Research: Clinical Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (8)
  3. John Wiley & Sons, Inc. (2)
  4. American Association for the Advancement of Science (1)
  5. American Society of Clinical Oncology (1)
  6. John Wiley & Sons (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploiting cutting-edge technologies to analyze loss of HLA in a global multicentric cohort of post-transplantation relapses: Preliminary results from the HLALOSS collaborative study
    Meeting Abstract

    Vago, L.; Toffalori, C.; Müberra, A.; Lange, V.; Lange, K.; Todaro, S.; Stempelmann, K.; Heinold, A.; Stölzel, F.; Waterhouse, M.; more...
    HLA (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • PHF6 mutations defines a subgroup of mixed phenotype of acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Xiao, W.; Pastore, F.; Getta, B.; Hultquist, A.; Shaffer, B. C.; Giralt, S. A.; Rampal, R. K.; Arcila, M. E.; Levine, R. L.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • KIR3DL1/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation
    Journal Article

    Boudreau, J. E.; Giglio, F.; Gooley, T. A.; Stevenson, P. A.; Le Luduec, J. B.; Shaffer, B. C.; Rajalingam, R.; Hou, L.; Hurley, C. K.; Noreen, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • How important is NK alloreactivity and KIR in allogeneic transplantation?
    Journal Article

    Shaffer, B. C.; Hsu, K. C.
    Best Practice and Research: Clinical Haematology (2016)

    Fulltext@MSK | Save
  • High progression-free survival (PFS) in adult double unit cord blood (dCB) transplant recipients with high risk disease after a novel intermediate intensity conditioning regimen
    Meeting Abstract

    Kosuri, S.; Hilden, P.; Devlin, S. M.; Yoo, Y.; Lauer, E.; Peled, J. U.; Avecilla, S.; Castro-Malaspina, H.; Dahi, P.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save